IP Library › Granted Patent US 12,691,220
Granted Patent B2
US 12,691,220 · App. 18/908,633 · Granted Jul 28, 2026

Medical device adaptive control for hostile environment

Inventors: Jay Jyotindra Dave (Carlsbad, CA); Igor Nesterenko (San Diego, CA)
Assignee: CAREFUSION 303, INC.
A61M5/172A61M5/142G01D5/145G01J1/4209G01K3/005G01R31/3647G01R33/07G05B23/0259G16H20/17G16H40/40G16H40/67A61M2205/3317A61M2205/3368A61M2205/50A61M2205/8212
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,691,220
App. No.
18/908,633
Filed
Oct 7, 2024
Granted
Jul 28, 2026
Kind
B2
Art Unit
3783
USPC
604/507
Abstract

A medical device is configured to monitor, using one or more sensors, an environmental condition of a physical environment proximate to a medical device, and to determine when a value representative of the environmental condition exceeds a threshold for safe operation of the medical device with regard to care of a patient. Responsive to the value exceeding the threshold, an operation mode of the medical device is automatically switched from a first mode currently programmed for the care of the patient to a second mode, the second mode using different parameters than the first mode to control the medical device.

Claims (51)

1 . An infusion device, comprising:

an infusion pump;

a battery configured to power the infusion pump; and

a control unit,

wherein the control unit is configured to:

receive a set of parameters for an infusion to be delivered by the infusion device;

monitor a value representative of a condition of the battery;

determine, based on the set of parameters, a period of time to complete the infusion by the infusion device;

determine that the value representative of the condition of the battery exceeds a predetermined threshold of operation of the infusion pump within the period of time; and

after determining that the value exceeds the predetermined threshold,

switch an operation mode of the infusion device to reduce power provided from the battery to a hardware component associated with the infusion device while maintaining a current pumping operation of a pumping mechanism of the infusion device for the period of time.

2 . The infusion device of claim 1 , wherein the control unit is further configured to:

determine the predetermined threshold of operation of the infusion pump based on at least one of a care area in which the infusion device is located or a medical condition of a patient.

3 . The infusion device of claim 1 , wherein monitoring the value representative of the condition comprises detecting a temperature of the battery.

4 . The infusion device of claim 1 , further comprising a battery charger, and wherein the battery is configured to receive power from the battery charger.

5 . The infusion device of claim 1 , wherein switching the operation mode of the infusion device further comprises disabling a battery charger associated with the battery.

6 . The infusion device of claim 1 , wherein the control unit is further configured to:

determine, before monitoring the value representative of the condition, an error associated with the hardware component associated with the infusion device, the error comprising an indication of a predetermined error threshold being exceeded,

wherein monitoring the condition is in response to the predetermined error threshold being exceeded.

7 . The infusion device of claim 1 , wherein the condition comprises a temperature, and wherein switching the operation mode further comprises reducing the power provided from the battery to the hardware component associated with the infusion device after the temperature exceeds a predetermined temperature threshold.

8 . The infusion device of claim 1 , wherein the control unit is further configured to, after determining that the value exceeds the predetermined threshold:

determine that a battery capacity of the battery is insufficient to power the hardware component for a predetermined period of time; and

adjust an operation parameter associated with the hardware component to reduce a power load of the infusion device, and

wherein the control unit is further configured to, after adjusting the operation parameter, determine that the power load has been reduced to a level sufficient for the battery to power the hardware component for the predetermined period of time.

9 . The infusion device of claim 1 , further comprising a user interface device, and wherein the control unit is further configured to adjust a user interface presented via the user interface device to provide an indication of the switched operation mode.

10 . A machine-implemented method, comprising:

receiving a set of parameters for an infusion to be delivered by an infusion device;

monitoring a value representative of a condition of a battery that powers the infusion device;

determining, based on the set of parameters, a period of time to complete the infusion by the infusion device;

determining that the value representative of the condition of the battery exceeds a predetermined threshold of operation of an infusion pump of the infusion device within the period of time; and

after determining that the value exceeds the predetermined threshold:

switching an operation mode of the infusion device to reduce power provided from the battery to a hardware component associated with the infusion device while maintaining a current pumping operation of a pumping mechanism of the infusion device for the period of time.

11 . The machine-implemented method of claim 10 , further comprising:

determining the predetermined threshold of operation of the infusion pump based on at least one of a care area in which the infusion device is located or a medical condition of a patient associated with the infusion device.

12 . The machine-implemented method of claim 10 , wherein monitoring the value representative of the condition comprises detecting a temperature of the battery.

13 . The machine-implemented method of claim 10 , further comprising:

receiving, by the battery, power from a battery charger.

14 . The machine-implemented method of claim 10 , wherein switching the operation mode of the infusion device further comprises disabling a battery charger associated with the battery.

15 . The machine-implemented method of claim 10 , further comprising:

determining, before monitoring the value representative of the condition, an error associated with the hardware component associated with the infusion device, the error comprising an indication of a predetermined error threshold being exceeded,

wherein monitoring the condition is in response to the predetermined error threshold being exceeded.

16 . The machine-implemented method of claim 10 , wherein the condition comprises a temperature, and wherein switching the operation mode further comprises reducing the power provided from the battery to the hardware component associated with the infusion device after the temperature exceeds a predetermined temperature threshold.

17 . The machine-implemented method of claim 10 , further comprising, after determining that the value exceeds the predetermined threshold:

determining that a battery capacity of the battery is insufficient to power the hardware component for a predetermined period of time; and

adjusting an operation parameter associated with the hardware component to reduce a power load of the infusion device,

wherein, after the operation parameter is adjusted, determining that the power load has been reduced to a level sufficient for the battery to power the hardware component for the predetermined period of time.

18 . The infusion device of claim 10 , further comprising:

providing a user interface for display via a user interface device; and

adjusting the user interface to provide an indication of the switched operation mode.

19 . The infusion device of claim 1 , wherein the period of time is set by a user via a configuration menu displayed on a display screen associated with the infusion pump, or is provided to the infusion pump by a hospital information server.

20 . The machine-implemented method of claim 10 , wherein the period of time is set by a user via a configuration menu displayed on a display screen associated with the infusion pump, or is provided to the infusion pump by a hospital information server.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2025
From: DAVE, JAY JYOTINDRA; NESTERENKO, IGOR
To: CAREFUSION 303, INC.
Reel/Frame 072392/0639 →
Continuity (4)
Continuation 18391561 · Dec 20, 2023
Continuation 17000225 · Aug 21, 2020
Provisional Application 62891869 · Aug 26, 2019
Related Publication 20250025630A1 · Jan 23, 2025
References Cited (206)
US 5637093A · Hyman et al. · 1997 [cited by applicant]
US 5712795A · Layman · 1998 [cited by examiner]
US 5713856A · Eggers et al. · 1998 [cited by applicant]
US 5781442A · Engleson et al. · 1998 [cited by applicant]
US 6519569B1 · White et al. · 2003 [cited by applicant]
US 7017061B2 · Lippert · 2006 [cited by examiner]
US 7945452B2 · Fathallah et al. · 2011 [cited by applicant]
US 7999810B1 · Boice et al. · 2011 [cited by applicant]
US 8078983B2 · Davis et al. · 2011 [cited by applicant]
US 8235938B2 · Eggers et al. · 2012 [cited by applicant]
US 8287514B2 · Miller · 2012 [cited by examiner]
US 8359338B2 · Butterfield et al. · 2013 [cited by applicant]
US 8435206B2 · Evans et al. · 2013 [cited by applicant]
US 8486019B2 · White et al. · 2013 [cited by applicant]
US 8553039B1 · Boice et al. · 2013 [cited by applicant]
US 9177108B2 · Garibaldi et al. · 2015 [cited by applicant]
US 9919158B2 · Ellingson et al. · 2018 [cited by applicant]
US 9971871B2 · Arrizza et al. · 2018 [cited by applicant]
US 9981124B2 · Jenison et al. · 2018 [cited by applicant]
US 10275571B2 · Coffman et al. · 2019 [cited by applicant]
US 10625015B2 · Garibaldi et al. · 2020 [cited by applicant]
US 11289180B2 · Vik et al. · 2022 [cited by applicant]
US 11324880B2 · Garibaldi et al. · 2022 [cited by applicant]
US 11901058B2 · Vik et al. · 2024 [cited by applicant]
US 12028414B1 · Borges et al. · 2024 [cited by applicant]
US 12121696B2 · Garibaldi et al. · 2024 [cited by applicant]
US 12205703B2 · Vik et al. · 2025 [cited by applicant]
US 12278868B2 · Borges et al. · 2025 [cited by applicant]
US 20020019714A1 · Carliale et al. · 2002 [cited by applicant]
US 20020038392A1 · De La Huerga · 2002 [cited by applicant]
US 20020071076A1 · Webb et al. · 2002 [cited by applicant]
US 20020099273A1 · Bocionek et al. · 2002 [cited by applicant]
US 20020188259A1 · Hickle et al. · 2002 [cited by applicant]
US 20020193679A1 · Malave et al. · 2002 [cited by applicant]
US 20030009244A1 · Engleson et al. · 2003 [cited by applicant]
US 20030069614A1 · Bowman et al. · 2003 [cited by applicant]
US 20030139701A1 · White et al. · 2003 [cited by applicant]
US 20030140928A1 · Bui et al. · 2003 [cited by applicant]
US 20030140929A1 · Wilkes et al. · 2003 [cited by applicant]
US 20030141981A1 · Bui et al. · 2003 [cited by applicant]
US 20030144878A1 · Wilkes et al. · 2003 [cited by applicant]
US 20030200117A1 · Manetta et al. · 2003 [cited by applicant]
US 20040019464A1 · Martucci et al. · 2004 [cited by applicant]
US 20040030323A1 · Ullestad et al. · 2004 [cited by applicant]
US 20040032426A1 · Rutledge et al. · 2004 [cited by applicant]
US 20040078231A1 · Wilkes et al. · 2004 [cited by applicant]
US 20040167465A1 · Mihai et al. · 2004 [cited by applicant]
US 20040167804A1 · Simpson et al. · 2004 [cited by applicant]
US 20040172222A1 · Simpson et al. · 2004 [cited by applicant]
US 20040172301A1 · Mihai et al. · 2004 [cited by applicant]
US 20040172302A1 · Martucci et al. · 2004 [cited by applicant]
US 20040176667A1 · Mihai et al. · 2004 [cited by applicant]
US 20050010447A1 · Miyasaka et al. · 2005 [cited by applicant]
US 20050038332A1 · Saidara et al. · 2005 [cited by applicant]
US 20050055242A1 · Bello et al. · 2005 [cited by applicant]
US 20050055244A1 · Mullen et al. · 2005 [cited by applicant]
US 20050065817A1 · Mihai et al. · 2005 [cited by applicant]
US 20050108057A1 · Cohen et al. · 2005 [cited by applicant]
US 20050140498A1 · Bastian, II · 2005 [cited by applicant]
US 20050171512A1 · Flaherty · 2005 [cited by applicant]
US 20050267402A1 · Stewart et al. · 2005 [cited by applicant]
US 20060026205A1 · Butterfield · 2006 [cited by applicant]
US 20060081257A1 · Krogh et al. · 2006 [cited by applicant]
US 20060098666A1 · Francis Conde Powell · 2006 [cited by applicant]
US 20060129202A1 · Armstrong · 2006 [cited by applicant]
US 20060167722A1 · Mrf Struys et al. · 2006 [cited by applicant]
US 20060189926A1 · Hall et al. · 2006 [cited by applicant]
US 20060206356A1 · Vanderveen · 2006 [cited by applicant]
US 20060229557A1 · Fathallah et al. · 2006 [cited by applicant]
US 20070041626A1 · Weiss et al. · 2007 [cited by applicant]
US 20070098565A1 · Parsee et al. · 2007 [cited by applicant]
US 20070124002A1 · Estes et al. · 2007 [cited by applicant]
US 20070145137A1 · Mrowiec · 2007 [cited by applicant]
US 20070210157A1 · Miller · 2007 [cited by applicant]
US 20070233521A1 · Wehba et al. · 2007 [cited by applicant]
US 20070251835A1 · Mehta et al. · 2007 [cited by applicant]
US 20070254593A1 · Jollota et al. · 2007 [cited by applicant]
US 20070258395A1 · Jollota et al. · 2007 [cited by applicant]
US 20070267475A1 · Hoglund et al. · 2007 [cited by applicant]
US 20080071251A1 · Moubayed et al. · 2008 [cited by applicant]
US 20080086333A1 · Hertel et al. · 2008 [cited by applicant]
US 20080125657A1 · Chomas et al. · 2008 [cited by applicant]
US 20080148040A1 · Machani et al. · 2008 [cited by applicant]
US 20080161664A1 · Mastrototaro · 2008 [cited by examiner]
US 20080201169A1 · Galasso et al. · 2008 [cited by applicant]
US 20080275422A1 · Ross · 2008 [cited by applicant]
US 20080281167A1 · Soderberg et al. · 2008 [cited by applicant]
US 20080294142A1 · Patel et al. · 2008 [cited by applicant]
US 20090063402A1 · Hayter · 2009 [cited by applicant]
US 20090069745A1 · Estes et al. · 2009 [cited by applicant]
US 20090069749A1 · Miller et al. · 2009 [cited by applicant]
US 20090153058A1 · Feng et al. · 2009 [cited by applicant]
US 20090156990A1 · Wenger et al. · 2009 [cited by applicant]
US 20090156991A1 · Roberts · 2009 [cited by applicant]
US 20090157040A1 · Jacobson et al. · 2009 [cited by applicant]
US 20090157695A1 · Roberts · 2009 [cited by applicant]
US 20090183105A1 · Teel, IV et al. · 2009 [cited by applicant]
US 20090271729A1 · Killoren Clark et al. · 2009 [cited by applicant]
US 20090275886A1 · Blomquist et al. · 2009 [cited by applicant]
US 20100121170A1 · Rule · 2010 [cited by applicant]
US 20100121654A1 · Portnoy et al. · 2010 [cited by applicant]
US 20100160860A1 · Celentano et al. · 2010 [cited by applicant]
US 20100271218A1 · Hoag et al. · 2010 [cited by applicant]
US 20100292645A1 · Hungerford et al. · 2010 [cited by applicant]
US 20110006876A1 · Moberg et al. · 2011 [cited by applicant]
US 20110009813A1 · Rankers · 2011 [cited by applicant]
US 20110009814A1 · Tsoukalis · 2011 [cited by applicant]
US 20110029324A1 · Kondo et al. · 2011 [cited by applicant]
US 20110072379A1 · Gannon et al. · 2011 [cited by applicant]
US 20110238032A1 · McTaggart et al. · 2011 [cited by applicant]
US 20110259954A1 · Bartz et al. · 2011 [cited by applicant]
US 20110264044A1 · Bartz et al. · 2011 [cited by applicant]
US 20110279079A1 · Do Valle · 2011 [cited by examiner]
US 20120029941A1 · Malave et al. · 2012 [cited by applicant]
US 20120215169A1 · Moberg et al. · 2012 [cited by applicant]
US 20120220928A1 · Estes et al. · 2012 [cited by applicant]
US 20120283691A1 · Barnes et al. · 2012 [cited by applicant]
US 20120284552A1 · Archer, Jr. · 2012 [cited by examiner]
US 20120310152A1 · Wehba et al. · 2012 [cited by applicant]
US 20120323090A1 · Bechtel et al. · 2012 [cited by applicant]
US 20130047113A1 · Hume et al. · 2013 [cited by applicant]
US 20130055106A1 · Tarneberg et al. · 2013 [cited by applicant]
US 20130104120A1 · Arrizza et al. · 2013 [cited by applicant]
US 20130138452A1 · Cork et al. · 2013 [cited by applicant]
US 20130148532A1 · Poon et al. · 2013 [cited by applicant]
US 20130152005A1 · McLaren et al. · 2013 [cited by applicant]
US 20130185098A1 · Mitchel et al. · 2013 [cited by applicant]
US 20130218080A1 · Peterfreund et al. · 2013 [cited by applicant]
US 20130248426A1 · Pouchoulin · 2013 [cited by applicant]
US 20130253946A1 · Broselow · 2013 [cited by applicant]
US 20130283529A1 · Hayes et al. · 2013 [cited by applicant]
US 20130317753A1 · Kamen et al. · 2013 [cited by applicant]
US 20140039455A1 · Miller et al. · 2014 [cited by applicant]
US 20140068487A1 · Steiger et al. · 2014 [cited by applicant]
US 20140188516A1 · Kamen et al. · 2014 [cited by applicant]
US 20140276536A1 · Estes · 2014 [cited by applicant]
US 20140276560A1 · Sehgal et al. · 2014 [cited by applicant]
US 20140323959A1 · Lebel et al. · 2014 [cited by applicant]
US 20150154364A1 · Biasi et al. · 2015 [cited by applicant]
US 20150196709A1 · Jacobson · 2015 [cited by examiner]
US 20150356253A1 · Sims et al. · 2015 [cited by applicant]
US 20150356255A1 · Simpson et al. · 2015 [cited by applicant]
US 20160038163A1 · Thor et al. · 2016 [cited by applicant]
US 20160077159A1 · Petrucelli · 2016 [cited by examiner]
US 20160103960A1 · Hume et al. · 2016 [cited by applicant]
US 20170061083A1 · Jackson · 2017 [cited by applicant]
US 20170128668A1 · Miller et al. · 2017 [cited by applicant]
US 20170266378A1 · Kamen et al. · 2017 [cited by applicant]
US 20180165422A1 · Mirov · 2018 [cited by applicant]
US 20180193561A1 · Susi · 2018 [cited by applicant]
US 20180309314A1 · White, II · 2018 [cited by examiner]
US 20200023127A1 · Simpson et al. · 2020 [cited by applicant]
US 20200051190A1 · Kamen et al. · 2020 [cited by applicant]
US 20200206413A1 · Silkaitis et al. · 2020 [cited by applicant]
US 20200357500A1 · Rubalcaba, Jr. et al. · 2020 [cited by applicant]
US 20210068683A1 · Reich · 2021 [cited by applicant]
US 20210146117A1 · Reich et al. · 2021 [cited by applicant]
US 20220001106A1 · DiPerna et al. · 2022 [cited by applicant]
US 20250032715A1 · Dobbles et al. · 2025 [cited by applicant]
CN 1561241A · 2005 [cited by applicant]
CN 101360453A · 2009 [cited by applicant]
CN 102387217A · 2012 [cited by applicant]
CN 102614561A · 2012 [cited by applicant]
CN 104689415A · 2015 [cited by applicant]
CN 105074765A · 2015 [cited by applicant]
CN 106075652A · 2016 [cited by applicant]
CN 207925143U · 2018 [cited by examiner]
CN 110168654A · 2019 [cited by applicant]
EP 1716878A1 · 2006 [cited by applicant]
JP 2000042103A · 2000 [cited by applicant]
JP 2005501340A · 2005 [cited by applicant]
JP 2008535634A · 2008 [cited by applicant]
JP 2009151806A · 2009 [cited by applicant]
JP 2012128554A · 2012 [cited by applicant]
JP 2013179973A · 2013 [cited by applicant]
WO WO03019402A1 · 2003 [cited by applicant]
WO WO2005086819A2 · 2005 [cited by applicant]
WO WO2006110851A2 · 2006 [cited by applicant]
CN207925143U-translation (Year: 2018). [cited by examiner]
Australian Office Action for Application No. 2020337414, dated Jun. 29, 2023, 3 pages. [cited by applicant]
Canadian Office Action for Application No. 3,149,532, dated Feb. 29, 2024, 6 pages. [cited by applicant]
International Preliminary Report on Patentability from the International Preliminary Examining Authority for Application No. PCT/US2020/047839, dated Dec. 8, 2021, 9 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2020/047839, dated Feb. 1, 2021, 18 pages. [cited by applicant]
Invitation to Pay Additional Fees and Partial International Search Report for Application No. PCT/US2020/047839, dated Dec. 2, 2020, 14 pages. [cited by applicant]
Qiu et al., “A survey of machine learning for big data processing”, EURASIP Journal Advances in Signal Processing, Mar. 28, 2016, Article No. 67 (2016), https://doi.org/10.1186/s13634-016-0355-x. [cited by applicant]
Written Opinion of the International Preliminary Examining Authority for Application No. PCT/US2020/047839, dated Aug. 25, 2021, 8 pages. [cited by applicant]
Chinese Office Action for Application No. 202080075122.0, dated Dec. 31, 2024, 22 pages including translation. [cited by applicant]
Zhang, et al., “Remote monitoring software to monitor the whole infusion points based on photoelectric sensor”, Journal of Clinical Rehabilitative Tissue Engineering Research, Issue 52, pp. 134-137. [cited by applicant]
Cardinal Health, (n.d.) IVAC PCAM Syringe Pump—Technical Service Manual, 1000SM00017, Issue 2 (2005-2006). 106 pages. [cited by applicant]
Cardinal Health, (n.d.). IVAC Volumetric Pump—Models 597 & 598, Technical Service Manual, 1000SM0016, Issue 3 (1998-2006). 76 pages. [cited by applicant]
CareFusion Corporation and Cerner Corporation Integrate Smart Pump Technologies to Help Improve Medication Safety and Efficiency. Biospace. Webpage. (Apr. 19, 2012). 10 pages. [cited by applicant]
Defendants Baxter Intl and Baxter Healthcare's Opening Brief in Support of Their Motion to Dismiss for Failure to State a Claim, Becton, [cited by applicant]
Defendants Baxter Intl and Baxter Healthcare's Reply Brief in Support of Their Motion to Dismiss for Failure to State a Claim, [cited by applicant]
Defendants Baxter Intl and Baxter Healthcare's Motion to Dismiss for Failure to State a Claim, [cited by applicant]
Plaintiffs' Answering Brief in Opposition to Defendants' Motion to Dismiss Pursuant to Fed R. Civ. P. 12(b)(6), [cited by applicant]
Sigma International, Inc. (Aug. 2008). Sigma Spectrum Infusion Pump Service Manual. P/N 41019. (Rev. T). 56 pages. [cited by applicant]
Sigma International, Inc. (Aug. 2009). Sigma Spectrum Infusion Pump Service Manual. P/N 41019. (Rev. W). 58 pages. [cited by applicant]
Sigma International. (May 15, 2008). sigmaspectrum operator's manual. Sigma P/N 41018. (Rev. X). 63 pages. [cited by applicant]
Sigma International. (Oct. 8, 2009). sigmaspectrum operator's manual. Sigma P/N 41018. (Rev. AL). 72 pages. [cited by applicant]
Sigma, LLC. (2010). sigmaspectrum Operator's Manual 35700ABB & 35700BAX. Sigma Manual No. 41018. (Rev. AR). 102 pages. [cited by applicant]
Sigma, LLC. (2010). sigmaspectrum Service Manual 35700ABB & 35700BAX. Sigma Manual No. 41019. (Rev. AA). 68 pages. [cited by applicant]
Sigma, LLC. (2011). sigmaspectrum Operator's Manual 35700BAX & 35700ABB. Manual 41018-6.05/6.2.4. (Rev. C). 119 pages. [cited by applicant]
Sigma, LLC. (2011). sigmaspectrum Operator's Manual 35700BAX & 35700ABB. Manual 41018-6.05/6.2.4. (Rev. D). 125 pages. [cited by applicant]
Chinese Notification to Grant for Application No. 202080075122.0, dated Mar. 6, 2026, 9 pages including translation. [cited by applicant]
Chinese Office Action for Application No. 202080075122.0, dated Dec. 25, 2025, 8 pages including translation. [cited by applicant]
Extended European Search Report for Application No. 25213296.4, dated Feb. 25, 2026, 10 pages. [cited by applicant]